News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aphios Selected by SAIC-Frederick, Inc. (SAI) to Develop Camposomes(TM) in Support of the National Cancer Institute’s Alliance for Nanotechnology in Cancer


2/1/2011 8:56:47 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aphios® Corporation today announced that it has entered into a subcontract with SAIC-Frederick, a subsidiary of Science Applications International Corporation, to develop phospholipid nanoencapsulated camptothecin, Camposomes™, for the treatment of pancreatic and other cancers, supporting the NCI Alliance for Nanotechnology.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES